Supriya Lifescience Powers Ahead with a New 5 MWp Solar Facility

Mumbai : Supriya Lifescience Ltd., a cGMP-compliant company with a well-established presence in API manufacturing, has reaffirmed its commitment to sustainability with the inauguration of a state-of-the-art (SOTA) 5 MWp solar power facility in Nanded District, Maharashtra. The project was inaugurated by Dr. Satish Wagh, Chairman of Supriya Lifescience, who emphasized the company’s commitment to […]

Continue Reading

Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing

•    Supriya Lifescience becomes the first Indian company to receive nod for Esketamine Hydrochloride from Brazil’s health authority ANVISA. •    Supriya Lifescience have developed groundbreaking technique for low-cost manufacturing of Atorvastatin, which is worldwide used for a key treatment for controlling cholesterol and preventing cardiovascular disease. Mumbai : Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two […]

Continue Reading